dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2018-12-11T16:54:21Z
dc.date.available2018-12-11T16:54:21Z
dc.date.created2018-12-11T16:54:21Z
dc.date.issued2018-01-01
dc.identifierCurrent Pharmaceutical Design, v. 24, n. 12, p. 1325-1340, 2018.
dc.identifier1873-4286
dc.identifier1381-6128
dc.identifierhttp://hdl.handle.net/11449/171198
dc.identifier10.2174/1381612824666180417122625
dc.identifier2-s2.0-85049665999
dc.description.abstractHeterocyclic N-oxides have emerged as promising agents against a number of diseases and disorders, especially infectious diseases. This review analyzes the emergence and development of this scaffold in the medicinal chemistry, focusing mainly on the discovery of new heterocyclic N-oxide compounds with potent activity against tuberculosis, malaria and neglected tropical diseases (i.e. leishmaniasis and Chagas disease). A number of heterocyclic N-oxides are described herein, nevertheless, the following chemical classes deserve to be highlighted due to a large number of reports in the literature about their promising pharmacological effects: furoxan, benzofuroxan, quinoxaline 1,4-di-N-oxide, indolone N-oxide and benzimidazole N-oxide. In order to describe those most promising compounds, we included in this review only those most biologically active heterocyclic Noxide published since 2000.
dc.languageeng
dc.relationCurrent Pharmaceutical Design
dc.relation0,883
dc.rightsAcesso restrito
dc.sourceScopus
dc.subjectChagas disease
dc.subjectDrug discovery
dc.subjectHeterocyclic N-oxides
dc.subjectLeishmaniasis
dc.subjectMalaria
dc.subjectN-oxide compounds
dc.subjectNeglected tropical diseases
dc.subjectTuberculosis
dc.titleHeterocyclic N-oxides -A promising class of agents against tuberculosis, malaria and neglected tropical diseases
dc.typeOtros


Este ítem pertenece a la siguiente institución